Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort.
M Javad WahadatHongchao QiCornelia G van Helden-MeeuwsenErika HuijserLotte van den BergAnnette van Dijk-HummelmanJens C GöpfertAnne HeineMarleen VerkaaikMarco W J SchreursWillem A DikSylvia KamphuisMarjan A VersnelPublished in: Rheumatology (Oxford, England) (2022)
Serum IFNα2 levels measured by Simoa technology are associated with disease activity scores and characterize disease activity states in cSLE.